GL
ZBH icon

Graypoint LLC’s Zimmer Biomet ZBH Stock Holding History

Graypoint LLC’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$297K Sell
3,255
-311
-9% -$30.1K 0.02% 438
2025
Q1 		$404K Sell
3,566
-430
-11% -$46K 0.03% 343
2024
Q4 		$422K Sell
3,996
-833
-17% -$89.4K 0.03% 343
2024
Q3 		$521K Buy
4,829
+299
+7% +$32.6K 0.03% 298
2024
Q2 		$492K Buy
4,530
+288
+7% +$34K 0.03% 283
2024
Q1 		$560K Buy
4,242
+363
+9% +$45.3K 0.04% 258
2023
Q4 		$472K Buy
+3,879
New +$433K 0.04% 271

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Graypoint LLC's ZBH Position: Q2 2025 in Review

Graypoint LLC reduced its Zimmer Biomet (ZBH) stake by 8.7% in Q2 2025, selling an estimated $30.1K and leaving 3,255 shares worth $297K. The position accounts for 0.02% of the portfolio, ranked #438.

Graypoint LLC first reported a position in ZBH in Q4 2023 and has held it in 7 quarters since. The position peaked at $560K in Q1 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Graypoint LLC held 3,255 shares of Zimmer Biomet worth $297K as of Q2 2025.
  • Graypoint LLC sold 311 Zimmer Biomet shares in Q2 2025, an estimated $30.1K.
  • Zimmer Biomet made up 0.02% of Graypoint LLC's portfolio in Q2 2025, its #438 holding.
  • Graypoint LLC first reported a position in Zimmer Biomet in Q4 2023 and has held it in 7 quarters since.
  • Graypoint LLC's Zimmer Biomet position peaked at $560K in Q1 2024.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.